Other
Our Office Closed Dec. 29 - Jan 3
Our office will be closed for winter holidays from Tuesday 29th December 2015 to Sunday 3rd January 2016. Please understand that our earlies...
License-Out
License Agreement Has Been Entered with Applied StemCell, Inc.
We executed a non-exclusive license agreement with Applied StemCell, Inc. which provides iPS cell derived cells and services for iPS cell ge...
Event
BIO-Europe2015 in Germany
We presented our exhibition in Japan Pavilion hosted by JETRO at “BIO-Europe2015” in Munich, Germany from November 2nd (Mon.) till November ...
License-Out
License Agreement Has Been Entered with Cartilize Incorporated
We executed a license agreement with Cartilize Incorporated which provides iPS cell-derived chondrocyte products for use in therapeutic appl...
Event
BioJapan2015 in Yokohama
We very much appreciate your visits to our booth at “BioJapan2015” in Yokohama from October 14th (Wed) till October 16th (Fri), 2015. The ex...
License-Out
License Agreement with Regenerative Medical Solutions
We executed a non-exclusive license agreement with Regenerative Medical Solutions which provides pancreatic cell products for research use, ...
License-In
License Agreement with Exploit Technologies Pte Ltd (ETPL), the commercialization arm of the Agency for Science, Technology and Research (A*STAR)
A non-exclusive license with a sublicensing right has been granted from ETPL, a leading TLO in Singapore, on 3 families of patents and paten...
License-Out
License Agreement Has Been Entered with Newcells Biotech
We executed a non-exclusive license agreement with Newcells Biotech Limited which provides iPS cells and iPS cell derived cells for research...
License-Out
License Agreement with STEMCELL Technologies Inc.
We executed a non-exclusive license agreement with STEMCELL Technologies Inc. which develop, manufacture, and distribute products for resear...
License-Out
License Agreement with Minerva Biotechnologies Corporation
A non-exclusive license agreement in non-clinical field products and services just executed with Minerva Biotechnologies on the patents rela...
